Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyHerman Goossens, Monique Elseviers, Matus Ferech et al.|The Lancet|2005Cited by 3.1k
Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyHerman Goossens, Monique Elseviers, Matus Ferech et al.|The Lancet|2005Cited by 1.4k
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, John C. Marshall et al.|Annals of the American Thoracic Society|2020Cited by 449
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysisElisa Gentilotti, Evelina Tacconelli, Pasquale De Nardo et al.|Clinical Microbiology and Infection|2021Cited by 103
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trialYehuda Carmeli, Surbhi Malhotra‐Kumar, José Miguel Cisneros et al.|The Lancet Infectious Diseases|2024Cited by 98